KT-474

Kymera’s protein degrader starts Phase II trial in atopic dermatitis
Clinical Trials Arena
Fri, 12/8/23 - 11:05 am
Kymera
Sanofi
protein degradation
clinical trials
atopic dermatitis
KT-474
First Protein Degrader Tested Outside Oncology Yields Promising Results
BioSpace
Wed, 12/14/22 - 07:23 pm
Kymera Therapeutics
Sanofi
protein degradation
hidradenitis suppurativa
atopic dermatitis
KT-474